Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain AXGN message board posts where the ticker symbol AXGN has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest AXGN SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001179110-18-010554 Size: 5 KB
2018-08-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001179110-18-010454 Size: 8 KB
2018-08-09
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001179110-18-010453 Size: 5 KB
2018-08-09
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001179110-18-010330 Size: 6 KB
2018-08-06
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001558370-18-006084 (34 Act)  Size: 4 MB
2018-08-01 001-36046
18984969
8-K  Documents Current report, items 2.02, 8.01, and 9.01
Acc-no: 0001558370-18-006082 (34 Act)  Size: 589 KB
2018-08-01 001-36046
18984878
8-K  Documents Current report, items 1.01, 5.02, and 9.01
Acc-no: 0001558370-18-005570 (34 Act)  Size: 338 KB
2018-07-12 001-36046
18949705
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001179110-18-009630 Size: 7 KB
2018-07-11
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001179110-18-009629 Size: 3 KB
2018-07-11
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001179110-18-008396 Size: 8 KB
2018-06-12
More AXGN SEC Filings


Related news from
Fri, 10 Aug 2018
17:40:14 +0000
Edited Transcript of AXGN earnings conference call or presentation 1-Aug-18 8:30pm GMT
Q2 2018 AxoGen Inc Earnings Call
Thu, 02 Aug 2018
19:44:00 +0000
Here's Why AxoGen, Inc. Fell as Much as 18.6% Today
The healthcare company reported second-quarter 2018 earnings.
Wed, 01 Aug 2018
21:30:35 +0000
AxoGen: 2Q Earnings Snapshot
On a per-share basis, the Alachua, Florida-based company said it had a loss of 20 cents. Losses, adjusted to extinguish debt and for stock option expense, were 9 cents per share. The regenerative medicine ...
Wed, 01 Aug 2018
20:16:07 +0000
AxoGen, Inc. Reports 2018 Second Quarter Financial Results
ALACHUA, Fla., Aug. 01, 2018-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today reported financial results and business highlights for ...
Fri, 27 Jul 2018
13:34:01 +0000
Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q1
Dr Reddy's (RDY) surpasses both earnings and sales year over year in the first quarter of fiscal 2019.
Fri, 27 Jul 2018
11:55:00 +0000
Free Stock Performance Review on Boston Scientific and Three Additional Medical Equipment Stocks
WallStEquities.com follows AxoGen Inc. (NASDAQ: AXGN), Boston Scientific Corp. (NYSE: BSX), Corindus Vascular Robotics Inc. (NYSE American: CVRS), and Edwards Lifesciences Corp. (NYSE: EW). Companies in the Medical Appliances and Equipment space are engaged in the manufacture of medical instruments, such as dental and surgical appliances.
Wed, 25 Jul 2018
11:00:00 +0000
AxoGen, Inc. to Present at Canaccord Genuity Growth Conference
ALACHUA, Fla., July 25, 2018-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Peter J. Mariani, Chief Financial Officer, ...
Tue, 24 Jul 2018
11:00:00 +0000
AxoGen, Inc. to Report Second Quarter 2018 Financial Results and Host Conference Call on August 1, 2018
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that it will report second quarter 2018 financial results on Wednesday, August 1, 2018 after the market closes. AxoGen management will host an investment-community conference call and webcast following the release at 4:30 p.m. ET to discuss the financial results and provide a corporate update. Investors interested in participating in the conference call by phone may do so by dialing toll free at (877) 407-0993 or use the direct dial-in number at (201) 689-8795.
Tue, 10 Jul 2018
11:00:00 +0000
AxoGen, Inc. Appoints Lisa N. Colleran to Board of Directors
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced it increased its Board of Directors to eight members and appointed Lisa N. Colleran as a director to fill the newly created position. Colleran was also appointed to the Audit Committee and the Governance and Nominating Committee.  “Lisa brings proven medical device and health care leadership, with strong market development and commercialization experience in fast growing companies,” commented Karen Zaderej, Chairman, Chief Executive Officer, and President.
Wed, 27 Jun 2018
11:10:00 +0000
Initiating Free Research Reports on Avinger and Three Other Medical Equipment Equities
Pre-market today, WallStEquities.com scans the following Medical Appliances and Equipment stocks: Amedica Corp. (NASDAQ: AMDA), Avinger Inc. (NASDAQ: AVGR), AxoGen Inc. (NASDAQ: AXGN), and Corindus Vascular Robotics Inc. (NYSE AMER: CVRS).
Tue, 26 Jun 2018
17:23:20 +0000
Is It Too Late To Buy AxoGen Inc (NASDAQ:AXGN)?
AxoGen Inc (NASDAQ:AXGN), a medical equipment company based in United States, received a lot of attention from a substantial price increase on the NasdaqCM over the last few months. AsRead More...
Fri, 08 Jun 2018
15:50:14 +0000
AxoGen Chairman and CEO Karen Zaderej Named Entrepreneur Of The Year 2018 Award Winner in Florida
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Ernst & Young (EY) named AxoGen Chairman and CEO Karen Zaderej as the Entrepreneur Of The Year® 2018 Award winner in the Health Care category in Florida. Zaderej was selected as an award winner by a panel of independent judges.
Wed, 06 Jun 2018
11:00:00 +0000
AxoGen, Inc. to Present at Upcoming Investor Conferences
William Blair 38 th Annual Growth Stock Conference, June 14 JMP Securities Life Sciences Conference, June 20. ALACHUA, Fla., June 06, 2018-- AxoGen, Inc., a global leader in developing and marketing innovative ...
Mon, 04 Jun 2018
11:40:00 +0000
Report: Developing Opportunities within Wix, AxoGen, YPF Sociedad Anonima, Orix Corp Ads, Travelport Worldwide, and Athene Holding — Future Expectations, Projections Moving into 2018
NEW YORK, June 04, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Wix.com ...
Mon, 04 Jun 2018
11:00:00 +0000
AxoGen, Inc. Appoints Kaila Krum Vice President, Investor Relations and Corporate Development
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced the appointment of Kaila Krum to the newly created position of Vice President, Investor Relations and Corporate Development, effective immediately. In this new role she will support and advance AxoGen’s investor relations program, focused on educating the financial community about the company’s platform for nerve repair, strategic growth plans, and business execution. Krum will report directly to Peter J. Mariani, Chief Financial Officer.
Tue, 29 May 2018
11:30:00 +0000
Complimentary Technical Snapshots on Avinger and Three More Medical Equipment Stocks
Under evaluation this morning are these four stocks: Avinger Inc. (NASDAQ: AVGR), AxoGen Inc. (NASDAQ: AXGN), Corindus Vascular Robotics Inc. (NYSE AMER: CVRS), and Edwards Lifesciences Corp. (NYSE: EW). Redwood City, California headquartered Avinger Inc.'s stock finished last Friday's session 2.03% higher at $2.01.
Tue, 29 May 2018
11:00:00 +0000
AxoGen, Inc. Announces Repayment in Full of its $25 million Outstanding Debt
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced that it repaid in full its outstanding debt with MidCap Financial (“MidCap”) on May 22, 2018. AxoGen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair.
Wed, 23 May 2018
11:00:00 +0000
AxoGen, Inc. to Present at the Jefferies Global Healthcare Conference
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Karen Zaderej, president and CEO, will present at the Jefferies Global Healthcare Conference in New York City. AxoGen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body.
Mon, 21 May 2018
11:01:00 +0000
AxoGen, Inc. Announces Appointment of Karen Zaderej as Chairman of the Board
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that its Board of Directors has elected Karen Zaderej as Chairman of the Board in addition to her current role as President and Chief Executive Officer (CEO), effective immediately. Zaderej succeeds Jamie M. Grooms, who will remain a Director of the Board. “As the founder of AxoGen, it has been a tremendous privilege to initiate and develop truly revolutionary products that improve quality of life for patients with peripheral nerve damage,” stated Jamie Grooms.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "The most important thing I have learned at VF in the last 3 years reading all you smart peoples posts is money management. This is usually not taught by our parents." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards